ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Clinical trial NCT04877275 · UNKNOWN

Trial details

NCT number: NCT04877275
Sponsor: Chunyan Sun, MD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2021-05-21
Primary completion: 2024-12-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.